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. While gB represents the fusion protein, two glycoprotein complexes control the tropism of the virus: the gHgLgO trimer is involved in the infection of fibroblasts, and the gHgLpUL128L pentamer is required for infection of endothelial, epithelial and myeloid cells [2] [3] [4] [5] . Two reports suggested that gB binds to ErbB1 and PDGFRα (refs 6,7) ; however, these results do not explain the tropism of the virus and were recently challenged 8, 9 . Here, we provide a 19 Å reconstruction for the gHgLgO trimer and show that it binds with high affinity through the gO subunit to PDGFRα, which is expressed on fibroblasts but not on epithelial cells. We also provide evidence that the trimer is essential for viral entry in both fibroblasts and epithelial cells. Furthermore, we identify the pentamer, which is essential for infection of epithelial cells, as a trigger for the ErbB pathway. These findings help explain the broad tropism of human cytomegalovirus and indicate that PDGFRα and the viral gO subunit could be targeted by novel anti-viral therapies.
Human cytomegalovirus (HCMV) is a widespread pathogen that establishes lifelong latency in healthy individuals 10 and can cause severe disease in immunodeficient individuals and in the fetus, being the leading viral cause of congenital birth defects 11 . VR1814 is a clinical HCMV isolate that can infect both fibroblasts and epithelial cells, and it expresses both the gHgLgO trimer and the gHgLpUL128L pentamer [2] [3] [4] [5] . In contrast, AD169 is a laboratory adapted virus that infects fibroblasts, but not epithelial cells 3, 12, 13 and expresses the trimer, but not the pentamer, due to a point mutation in the UL131 open reading frame (ORF) 2, 4 . Antibodies that bind to the shared gH glycoprotein neutralize infection of both fibroblasts and epithelial cells 14 , while antibodies to the pUL128 gene products are extremely potent in neutralizing the infection of epithelial, endothelial and myeloid cells, but fail to neutralize the infection of fibroblasts 14, 15 . Although it is well established that the trimer and pentamer determine the tropism of the virus 16 , the identity of their cellular receptors remain a matter of debate 1 .
To identify the mechanisms that underline the cellular tropism of different HCMV strains, we investigated the activation of receptor tyrosine kinases (RTKs) upon exposure of epithelial cells (ARPE- 19) or fibroblasts (MRC-9) to VR1814 or AD169 viruses ( Fig. 1a and Supplementary Fig. 1 ). Consistent with a previous report 7 , the pentamer-deficient AD169 virus led to the phosphorylation of PDGFRα and PDGFRβ in fibroblasts, but it failed to activate RTKs in epithelial cells (Fig. 1a) , a finding that is consistent with the inability of AD169 to infect this cell type 4, 12 . Interestingly, the clinical isolate VR1814 led to the phosphorylation of PDGFRα, PDGFRβ and ErbB1 in fibroblasts, while in epithelial cells it induced the phosphorylation of ErbB1 and, to a lesser extent, of ErbB2 and PDGFRβ (Fig. 1a) . These findings are consistent with the expression of ErbB1 on both cell types and PDGFRα on fibroblasts only (Supplementary Figs 2a,b and 3) . Thus, the PDGFRα pathway is triggered only in fibroblasts by both pentamer-deficient and pentamer-sufficient viruses, while the ErbB pathway is triggered only by the pentamer-sufficient VR1814 virus in both fibroblasts and epithelial cells. These data are inconsistent with a previous report that suggested that gB, which is expressed by both viruses, is a ligand for ErbB (ref. 6 ), but rather suggest that the pentamer might be the trigger of the ErbB pathway.
To study the molecular interactions that lead to the triggering of the PDGFR and ErbB pathways, we produced recombinant trimer and pentamer 15 and used them in immunoprecipitation experiments. The trimer immunoprecipitation performed on cell surface biotinylated fibroblasts showed a clear band above 150 kDa (Fig. 1b) , which was identified as PDGFRα by mass spectrometry analysis (Supplementary Table 1 ). In contrast, no specific band was obtained using pentamer on the cell surface biotinylated fibroblasts, but multiple bands were obtained using pentamer on epithelial cells (Fig. 1b and Supplementary Table 2) . Recombinant trimer and pentamer were also used for pulldown experiments followed by western blot analysis. Pulldowns confirmed a specific interaction between trimer and PDGFRα from fibroblasts, but not from epithelial cells (Fig. 1c) . These findings indicate that the HCMV trimer can bind to PDGFRα, which is selectively expressed on fibroblasts but not on epithelial cells, thus explaining the limited tropism of the pentamer-deficient AD169 virus 17 . In contrast, immunoprecipitation experiments failed to demonstrate a direct high-affinity interaction between the pentamer and ErbB receptors, leaving the possibility that this interaction may have low affinity or requires additional bridging molecules.
To further investigate the role of the ErbB and PDGFR pathways in the infection process, we used a genetic approach based on downregulation and knockout of specific receptors ( Supplementary  Fig. 4a,b) . Downregulation of ErbB1 and ErbB2 by shRNA reduced infection of epithelial cells and fibroblasts by the pentamersufficient VR1814 virus, but it did not affect infection of fibroblasts by the pentamer-deficient AD169 virus (Fig. 1d) . In contrast, downregulation of PDGFRα inhibited by 80% the infection of fibroblasts by AD169, but did not affect their infection by VR1814. To further validate these data we used a gene knockout approach in the haploid cell line HAP-1, which expresses PDGFRα and ErbB2, as well as low levels of ErbB3 ( Supplementary Fig. 2c ). CRISPR-Cas9-mediated knockout of ErbB2 and ErbB3, but not PDGFRα, strongly reduced infection of HAP-1 cells by VR1814 virus (Fig. 1e) . Reciprocally, knockout of PDGFRα, but neither ErbB2 nor ErbB3, completely inhibited infection by AD169. Of note, knockout of integrin β1, which has been shown to play a role as co-receptor in HCMV entry 18, 19 , did not affect infection by AD169 or VR1814 viruses (Fig. 1e) , a finding that suggests that multiple integrins may play a role as co-receptors in HCMV entry 18, 19 . Consistent results were obtained using a lentiviral-mediated overexpression approach ( Fig. 1f and Supplementary Fig. 4c,d ). ErbB2 overexpression in both epithelial cells and fibroblasts led to a two-to threefold higher infection by VR1814, while overexpression of PDGFRα in epithelial cells rendered the cells permissive to infection by the pentamer-deficient AD169 virus and increased infection by the VR1814 virus twofold (Fig. 1f ) . Collectively, the above results indicate that pentamer-sufficient VR1814 virus can trigger PDGFR and ErbB receptor tyrosine kinase pathways onto fibroblasts, while the pentamer-deficient AD169 virus relies only on PDGFRα.
To investigate the viral entry mechanisms into fibroblasts, we measured the capacity of antibodies and soluble ligands to inhibit infection. Fibroblasts infection by the AD169 virus was inhibited by all ligands that interfere with the trimer-PDGFRα interaction, namely soluble PDGFRα, soluble gHgLgO trimer, anti-PDGFRα, anti-gH and anti-gO monoclonal antibodies ( Fig. 2a and Supplementary Fig. 5a-d) . Infection of fibroblasts by the VR1814 virus was inhibited by an anti-gH antibody that targets both trimer and pentamer 14, 20 and a monoclonal anti-gO antibody ( Fig. 2b and Supplementary Fig. 5a-d) . Furthermore, although -19) or fibroblasts (MRC-9) were exposed to pentamer-sufficient virus (VR1814) or pentamer-deficient virus (AD169). After 10 min, the cells were lysed and the lysate was captured by antibodies specific for tyrosine kinase receptors and developed using an anti-phospho-tyrosine antibody. Coordinates of the phospho-receptor tyrosine kinase array are reported in Supplementary Fig. 1 . b, Soluble trimer and pentamer were used for immunoprecipitation of cell surface biotinylated proteins from MRC-9 or ARPE-19 cells, followed by immunoblotting with streptavidin-HRP conjugate. c, Pulldown from ARPE-19 or MRC-9 cells with soluble trimer or soluble pentamer immobilized on streptactin beads. Precipitated material was subjected to western blot analysis with an anti-PDGFRα polyclonal antibody. d, The indicated receptors were downregulated on ARPE-19 and MRC-9 by shRNA. Cells were then infected with VR1814 or AD169 viruses for 48 h. The percentage of infected cells is shown. e, The indicated receptors were knocked out on HAP-1 cells by CRISPR/Cas9. Cells were infected with VR1814 or AD169 viruses and analysed as above. f, The indicated receptors were overexpressed in ARPE-19 or MRC-9 cells using lentiviral vectors. Cells were infected and analysed as above. Data are means ± s.d. of three independent experiments. Statistical significance was evaluated by Mann-Whitney U test: ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. infection of fibroblasts by VR1814 was not affected by soluble trimer or pentamer when used alone, the combination of soluble trimer and pentamer was strongly inhibitory (Fig. 2c) . Similarly, fibroblasts infection by VR1814 was potently inhibited by a combination of anti-pUL128 antibody and either soluble PDGFRα or anti-gO antibody ( Fig. 2d and Supplementary Fig. 5a-c) .
Similar experiments using antibodies and soluble ligands were performed to address the mechanisms of viral entry into epithelial cells. Infection by VR1814 was strongly inhibited by anti-pUL128 antibody and, to a lower extent, by anti-gH antibody or soluble pentamer, as reported previously 14, 15, 21 (Fig. 2e) . Remarkably, a monoclonal anti-gO was also able to reduce ARPE-19 infection (Fig. 2e ). This surprising result suggests that the trimer might have a dual function of viral ligand and activator of gB fusogenic activity, as recently proposed 22, 23 . Because we did not find evidence for binding of the pentamer to ErbB receptors, we tested the inhibitory capacity of ErbB ligands, which downregulate the cognate receptors ( Supplementary Fig. 6 ). Interestingly, infection of epithelial cells was inhibited by pre-incubation of the cells with HB-EGF (which binds to ErbB1 and ErbB4), EGF (which binds to ErbB1) or Nrg-1 (which binds to ErbB4 on ARPE-19 cells) (Fig. 2f ) . These results support the notion that entry into epithelial cells relies on ErbB receptors.
To investigate the molecular interactions involved in the HCMV target cell tropism, we probed the trimer and pentamer with PDGFRα and ErbB1 using surface plasmon resonance (SPR) and biolayer interferometry (BLI). A high-affinity interaction between trimer and PDGFRα was detected using both SPR and BLI, with an equilibrium dissociation constant (K D ) of 2 × 10 −9 M (Fig. 3a,c ). The trimer-PDGFRα complex was still accessible to two neutralizing antibodies specific for gH (Fig. 3d) . Interestingly, soluble gHgL dimer did not bind to PDGFRα (Fig. 3d) , indicating that the gO component of the trimer is essential for binding. Similar SPR experiments performed with soluble pentamer and ErbB1-4 receptors or PDGFRα did not reveal any interactions ( Supplementary Fig. 7 ).
To further investigate the interaction between the gHgLgO trimer and PDGFRα, we studied complex formation in solution using size-exclusion chromatography and visualized the complexes by electron microscopy. The addition of PDGFRα to soluble trimer shifted the chromatography peak to a lower retention time, indicating the formation of a complex (Fig. 4a,b) . Addition of a Fab fragment of the anti-gH antibody 13H11 to the purified complex further decreased the retention time of the complex (Fig. 4c) . SDS-polyacrylamide gel electrophoresis (PAGE) analysis confirmed that the purified trimer-PDGFRα and 13H11-trimer-PDGFRα complexes contained all indicated components (Fig. 4d) . The images of the complexes formed were visualized by negative staining and transmission electron microscopy with two-dimensional averaging (Fig. 4e-h and Supplementary Fig. 8 ). The gHgLgO trimer alone presented a boot-shaped structure, where gHgL forms the elongated structure and gO the angled extension (Fig. 4e,h ), similar to recent reports 26 . Interestingly, and in agreement with the BLI results, the image of the gHgLgO trimer-PDGFRα complex revealed that only the gO subunit interacts with PDGFRα, and it appeared that three Ig-like domains of the PDGFRα were visible in the twodimensional averaged density, resembling the mode of interaction between platelet-derived growth factor and its receptor ( Supplementary Fig. 9 ). However, not all domains of PDGFRα were well-defined due to its flexibility 27 (Fig. 4f ) . This result was further confirmed by the observation that 13H11 Fab bound to a site of gH away from the gO interacting face and therefore did not interfere with binding of gO to PDGFRα (Figs 3c and 4g ). Consequently, we conclude that the neutralizing activity of 13H11 is not due to inhibition of the trimer-PDGFRα interaction, but may be dependent on its ability to interfere with the capacity of the complex to trigger gB and consequently viral fusion 20 . This study demonstrates that HCMV infection of fibroblasts relies on the direct interaction of the gHgLgO trimer with PDGFRα and identifies gO as the essential component for this interaction. In contrast, we could not find evidence of a direct interaction between the gHgLpUL128L pentamer and the ErbB receptors. However, using wild-type pentamer-deficient virus and cellular knockdown, we reported that the ErbB pathway activation might be involved in pentamer-dependent tropism. It is therefore tempting to suggest that HCMV pentamer induces ErbB activation, which in turn induces macropinocytosis. Indeed, this endocytic mechanism has already been proposed to mediate HCMV entry into epithelial cells 9, 24 .
The broad distribution of the PDGFRα and ErbB receptors is consistent with the ability of HCMV to infect different cell types, ranging from epithelial, endothelial, myeloid, haematopoietic precursors, neuronal, astrocytes and glial cells expressing either PDGFRα and/or the ErbB receptors 25 . The role of PDGFRα as a HCMV receptor was recently challenged by Vanarsdall and colleagues 9 who showed that PDGF-AA and anti-PDGFRα antibodies did not block infection of fibroblasts by a HCMV clinical isolate. These results are in agreement with our finding. Pentamer-sufficient virus might alter the nature of the entry pathway by inducing viral endocytosis. Two previous studies have suggested that gB binds to ErbB1 or PDGFRα (refs 6,7) . However, this model is inconsistent with the differential tropism of wild-type and pentamer-deficient viruses, as both viruses express gB. In addition, a recent experiment showing that gB expressed on target cells can promote the fusion of gB-deficient trimer-expressing virus might suggest that gB lacks a cellular receptor 26 . It is therefore tempting to suggest that the interaction of gB with ErbB1 and PDGFRα might be mediated by pentamer and trimer, respectively. Indeed, HCMV trimer might have the dual function of cellular receptor binding and trigger of gB fusogenic activity as proposed recently 22, 23 and similarly to what is described for gD in HSV-1 (ref. 27 ). e-h, Negative-stain electron microscopy and reference-free two-dimensional class averages of gHgLgO and its complexes purified by size exclusion chromatography. One representative image from each purification step was zoomed in to show the shape of the molecules and addition of volume: trimer alone (e) or with receptor PDGFRα bound to gO (f,g). Of note, for the gHgLgO-PDGFRα complex, PDGFRα is only well resolved in some averages (f) or with the 13H11 Fab bound to the twisted region of gH in the gHgLgO-PDGFRα complex (g). In h, electron density for the three-dimensional map of gHgLgO is shown at 19.3 Å resolution. *13H11 Fab eluted at lower apparent molecular weight possibly due to interactions at the column resin.
Importantly, we also identified an anti-gO monoclonal antibody isolated from a HCMV seropositive donor. Surprisingly, this antibody neutralized HCMV VR1814 with the same potency on fibroblasts and epithelial cells, indicating that the gHgLgO trimeric complex is necessary for viral entry on all cell types. This finding is consistent with recent studies reporting gHgLgO as the only promoter of gB fusion 22, 23 . Nonetheless, gB-mediated fusion occurs at the plasma membrane in fibroblasts 28 , whereas viral fusion happens in the endosome of epithelial, endothelial and myeloid cells 9, 29, 30 , which do not express PDGFRα. It will be interesting to determine the mechanism of trimer-induced endosomal fusion in the absence of PDGFRα.
In conclusion, we have demonstrated that the HCMV trimer cellular receptor is PDGFRα. We have also shown that HCMV can use both PDGFR and ErbB pathway for cellular entry (Supplementary Fig. 10 ). The identification of multiple pathways may explain the broad HCMV tropism, and will assist in the development of anti-viral agents and vaccines, effectively controlling viral infection and dissemination.
Methods
Cells and viruses. ARPE-19 retinal pigmented epithelium cell line (ATCC CRL-2302) was cultured in D-MEM/F-12 (Gibco, Invitrogen) supplemented with 10% FBS and penicillin/streptomycin. The MRC-9 fibroblast cell line (ATCC CCL-212) was cultured in minimum essential Eagle medium (Sigma-Aldrich) supplemented with 10% FBS, glutamine and penicillin/streptomycin. HAP-1 cells, the parental line and HAP-1 CRISPR knockouts, were obtained from Horizon Genomics and cultured in Iscove's modified Dulbecco's medium (IMDM) in the presence of 10% FBS and penicillin/streptomycin. All cell lines were confirmed to be free of mycoplasma. HCMV clinical isolate VR1814 and laboratory-adapted strain AD169 were provided by Virologia e Microbiologia, Fondazione IRCCS Policlinico San Matteo. HCMV VR1814 and AD169 were propagated on HUVEC cells and fibroblasts, respectively. ARPE-19, MRC-9 and HAP-1 cells are not listed, according to ICLAC 3/10/2014. ARPE-19, MRC-9 and HAP-1 cells 31 were authenticated by analysis of short tandem repeat (STR) loci at ATCC (ARPE-19, MRC-9) and Horizon Genomics (HAP-1).
Cell surface biotinylation, immunoprecipitation, pulldown and western blotting. ARPE-19 and MRC-9 cells were grown to confluency in 10 cm culture dishes (Nunc, Thermo Scientific). Before biotinylation, cells were washed twice with ice-cold PBS and incubated with 2 ml 0.5 mg ml -1 sulfo-NHS-biotin in PBS per plate for 15 min (Thermo Scientific). Reactions were quenched by the addition of 10% FBS for 10 min on ice. Cells were washed twice with PBS and lysed with 1 ml per plate of icecold lysis buffer (1% n-dodecyl-β-D-maltoside, 50 mM Tris pH 7.2, 150 mM NaCl, 1× complete protease inhibitor from Roche). Centrifuged cell lysates were incubated with 30 µg of trimer or pentamer (pre-complexed with 30 µg 13H11 antibody) for 3 h with continuous shaking. Protein A beads were subsequently added to the cell lysates for 90 min. Beads were washed three times with lysis buffer and once with PBS, then boiled in reducing SDS-PAGE loading buffer and subjected to SDS-PAGE and western blotting. Detection was performed with streptavidin-horseradish peroxidase (HRP) conjugate (Upsala) in 1% BSA for 1 h at room temperature. For pulldown experiments, MRC-9 or ARPE-19 cell lysates were incubated with 30 µg trimer or pentamer for 3 h with continuous shaking. StrepTactin sepharose beads (GE Healthcare) were subsequently added to the cell lysates for 90 min. Beads were washed three times with lysis buffer and once with PBS, then boiled in reducing SDS-PAGE loading buffer and subjected to SDS-PAGE and western blotting. Detection was performed with rabbit polyclonal anti-PDGFR-α antibody (C-20, Santa Cruz Biotechnology) in 1% BSA for 2 h at room temperature. Uncropped images of western blots are provided in Supplementary Fig. 11 .
Enzyme-linked immunosorbent assay (ELISA). An ELISA was performed to ensure that the particles used for the experiments were similar in terms of gH derived glycoprotein content (trimer and pentamer). AD169 and VR1814 particles were coated on 96-well MaxiSorp plates (Nunc), blocked with 1% BSA in PBS, and incubated with titrated antibodies (13H11), followed by AP-conjugated goat anti-human IgG antibody (Southern Biotech, catalogue no. 2040-04). Plates were then washed, substrate (p-NPP, Sigma) was added and plates were read at 405 nm. (clone 6E1; Santa Cruz Biotechnology), mouse IgG2a H1P73 or mouse IgG2b (MA5-14447; Invitrogen) at 2 µg ml -1 for 30 min on ice for isotype control. After two washes, cells were incubated with the following secondary antibodies: goat antimouse IgG (H+L) AlexaFluor 594 conjugated (Invitrogen) at 2 µg ml -1 for 30 min on ice, washed twice and acquired with a FACSFortessa (BD Biosciences) flow cytometer. For intracellular staining, 293Expi cells were fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences) according to the manufacturer's instructions, and then stained with the anti-gO antibodies or 13H11 mab (as isotype control) at 2 µg ml -1 for 30 min on ice, washed and incubated with goat antiHuman IgG (H+L), AlexaFluor 594 conjugated (Invitrogen) at 2 µg ml -1 for 30 min on ice, washed twice and acquired with a FACSFortessa flow cytometer. Analysis was performed with FlowJo software.
Gene overexpression and down regulation. Human ErbB1, ErbB2, ErbB4 and PDGFRα were ordered from the GenEZ ORF database (Genscript). Lentiviral vectors were generated by cloning ErbB1, ErbB2, ErbB4 and PDGFRα in pCDH-EF1-MCS (System Biosciences). Lentiviral particles were generated by PEI transfection of HEK293FT (Invitrogen) with pCDH, pMD2.G (Addgene) and psPAX (Addgene) and purified on a sucrose cushion. ARPE-19 and MRC-9 were transduced at 60% confluency, and expression was assessed after 2 days. Downregulations of ErbB1, ErbB2 and PDGFRα were done by lentiviral transduction of cells using four unique 29mer shRNA constructs in pGFP-C-shLenti and 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector (Origene), according to the manufacturer's instructions. Best constructs were selected by puromycin selection and effective downregulation of the target gene without a decrease in cell viability. The sequences of the shRNAs used are as follows:
ErbB1: 5′_ATGGAGGAAGACGGCGTCCGCAAGTGTAA_3′ ErbB2: 5′_TGTTGGATGATTGACTCTGAATGTCGGCC_3′ ErbB4: 5′_TGTAAGGCAATGCTGCCTACTATCAAACT_3′ PDGFRα: 5′-AGTTCCACCTTCATCAAGAGAGAGGACGA_3′ Scrambled: 5′_GCACTACCAGAGCTAACTCAGATAGTACT_3′
HAP-1 CRISPR/Cas9 KO. HAP1-PDGFRα KO was obtained by causing a frameshift mutation (insertion of 176 bp in exon 2) in PDGFRα (NM-006206). As a result, the defective transcript had the amino-acid sequence MGTSHPARSHVISVCSAT*. The guide RNA had the sequence 5′-CAGCCTAAGACCAGGAACGC-3′. The clone was verified by PCR and Sanger sequencing and the following primers were used: PCR_fwd: TGTAAAACGACGGCCAGTCAGAAGGTTTTGGCTTCAGG PCR_bwd: AACTGCCACTGGAGAGCATT Sequencing primer: TGTAAAACGACGGCCAGTCAGAAGGTTTTGGCTTCAGG The sequencing result was 5′_ATGGGGACTTCCCATCCGGCGCGCAGTCAC GTGATCAGTGTATGTTCAGCCACGTGATCAGTGCATGATAGCAAACTG ATCAGTGCACATTAAGGAACGTGATTAGTGCATGATCAGCCACGTG ATAAGTGTACAATGAGACACGTGATCAGTGCATGATCAGCCACG TAATCAGTGCATGATAGCCACCTGATCAGTTCCTGGTCTTAGGCTGTC_ 3′.
HAP1-ErbB2 KO was obtained by causing a frameshift mutation (10 bp deletion in exon 6) in ErbB2 (NM_001005862). As a result, the defective transcript had the amino-acid sequence MKLRLPASPETHLDMLRHLYQGCQVVGNLEL TYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALA VLDNGDPLNNTTPVTGASPGGLRFEASQRS*.
The guide RNA had the sequence 5′_TTCGAAGCTGCAGCTCCCGC_3′. The clone was verified by PCR and Sanger sequencing, and the following primers were used:
PCR_fwd: CTCATCGCTCACAACCAAGTGA PCR_bwd: GAATTATATGTGCTGACGCAAGCTA Sequencing primer: CTCATCGCTCACAACCAAGTGA The sequencing result was 302: 5′_GGCCTCCCCAGGAGGCCTGC----------GCTTCGAAGCCTCACAG_3′.
HAP1-ErbB3 KO was obtained by causing a frameshift mutation (4 bp deletion in exon 3) in ErbB3 (NM_001982). As a result, the defective transcript had the amino-acid sequence MRANDALQVLGLLFSLARGSEVGNSQAVCPGTLNG LSVTGDAENQYQTLYKLYERCEVVMGNLEIVLTGHNADLSFLQWIREVTG YVLVAMNEFSTLPLPNLRCEGPRSTMGSLPSSSC*.
The guide RNA had the sequence 5′_ACCATTGCCCAACCTCCGCG_3′. The clone was verified by PCR and Sanger sequencing and the following primers were used:
PCR_fwd: TGTAAAACGACGGCCAGTGGCAACAAGAGCGTAACTCC PCR_bwd: TTGCTTAGGGAGCAATGGACCT Sequencing primer: TGTAAAACGACGGCCAGTGGCAACAAGAGCGTAAC TCC The sequencing result was 287: 5′_TCTACCATTGCCCAACCTCC-----GGTGCG AGGGACCCAGGTCT_3′.
HAP1-Integrinβ1 KO was obtained by causing a frameshift mutation (10 bp deletion in exon 4) in ITGBI (NM_002211). As a result, the defective transcript had the amino-acid sequence MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGE CIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDIENPRGSKDI KKNKNVAKEQQRSSSQRILLRSNHSSWFCD*.
The guide RNA had the sequence 5′-TGCTGTTCCTTTGCTACGGT-3′. The clone was verified by PCR and Sanger sequencing and the following primers were used:
PCR_fwd: TGTAAAAACGAGCCTTCAACAGAAA PCR_bwd: ACTTCTGCACGATGTGATGATTTAG Sequencing primer: TGTAAAAACGAGCCTTCAACAGAAA The sequencing result was 517:_5′CTGTGGTTGGATCTGAGTAATA TCCTCTGGCTTGAGCTTCTCTGCTGTTCCTTTGCTACATTTTTA TTTTTCTTTATATCTTTGGAGCCTCTGGGATTTTCTATGTCATCTGGA_ 3′.
Human phospho-RTK array. The human phospho-RTK array was obtained with a kit (R&D systems, catalogue no. ARY-001B). ARPE-19 and MRC-9 were grown in T75 plates (total of four million cells) and infected with the different virus strains for 10 min with a multiplicity of infection (MOI) of 1. Both viruses were purified by ultracentrifugation on a sucrose gradient and dialysed against PBS with a membrane cutoff of 100 kDa to remove proteins and small molecules that could co-sediment with the viruses. Both viruses were considered similar for the overall content of gH-derived glycoprotein and gO content. Glycoprotein O content for AD169 and VR1814 viruses was analysed by western blot (Supplementary Fig. 5c ). Glycoprotein H quantity was analysed by both mass spectrometry (Supplementary Table 3 , PRIDE repository data set identifier PXD003810) and ELISA ( Supplementary Fig. 5d ).
Monoclonal antibody isolation from memory B cells. Memory B cells were isolated from cryopreserved peripheral blood mononuclear cells (PBMCs) using CD22 microbeads or anti-FITC (fluorescein isothiocyanate) microbeads (Miltenyi Biotec) after staining of PBMCs with CD22-FITC, and were immortalized with Epstein-Barr virus (EBV) and CpG in multiple wells, as described previously 32 . Supernatants of immortalized memory B cells collected after 2 weeks were screened for their ability to bind gO or neutralize HCMV virus (AD169) infections in highthroughput fluorescence-activated cell sorting (FACS) and micro-neutralization assays, respectively. Positive EBV-B cell cultures were expanded in complete Roswell Park Memorial Institute medium (RPMI) medium. The antibodies were affinity purified by protein A chromatography (GE Healthcare).
Negative-stain electron microscopy and single-particle analysis. gHgLgO, gHgLgO-PDGFR and 13H11-gHgLgO-PDGFR complexes were diluted to ∼0.01 mg ml -1 , adsorbed to freshly glow-discharged carbon-film grids for 15 s, washed with a buffer containing 20 mM HEPES, pH 7.5, and 150 mM NaCl, and stained with 0.7% uranyl formate, pH 5. Images were collected semi-automatically with SerialEM 33 on an FEI Tecnai T20 operating at 200 kV and equipped with a 2,000 × 2,000 Eagle charge-coupled device camera at a pixel size of 0.22 nm pixel -1 . Particles were picked automatically and manually using e2boxer from the EMAN2 software package 34 . Initial reference-free two-dimensional class averages were obtained in EMAN2. Further two-dimensional classification was performed using reference-free alignment and correspondence analysis in SPIDER 35 . The numbers of particles used for two-dimensional analysis were 10,356 (gHgLgO), 43,000 (gHgLgO-PDGFR) and 12,947 (13H11-gHgLgO-PDGFR).
To obtain the three-dimensional map of gHgLgO, the data set containing 10,356 particles was subjected to iterative stable alignment and clustering (ISAC) 36 in SPARX 37 . The ISAC classes were then used to generate an initial three-dimensional map in EMAN2, which was used as the initial model for three-dimensional reconstruction and refinement using reference projections in SPIDER 38 . The resolution of the final map was 19.3 Å when a Fourier shell correlation (FSC) threshold of 0.5 was used. The map was visualized in UCSF Chimera 39 .
PDGFRα, pentamer, trimer and dimer expression and purification. The extracellular domain of PDGFRα with the C-terminal encoding a twin strep and eight histidine tags was produced in HEK 293 GnTI −/− cells via transient transfection. Cell supernatant was batch-incubated with 5 ml complete His-Tag purification resin (Roche) at room temperature for 30 min with continuous inversion mixing. Imidazole (6 mM) was added to reduce non-specific binding. The resin was packed into a column and sequentially washed with three column volume of buffers containing 6 and 15 mM imidazole in 400 mM NaCl, 20 mM Tris/Cl − pH 7.5. The protein was eluted with the same buffer containing 300 mM imidazole. Expression and purification of the soluble pentamer has been described previously by our group 15 . Soluble trimer complex was generated using a single polycistronic vector encoding three genes (gH, gL and gO). The gH subunit lacking the transmembrane domain and modified at the C-terminus by the addition of a TEV cleavage site, a twin strep and six histidine tags was separated from gL by a selfcleaving 2A peptide. The gHgL and gO subunits were cloned, respectively, in pEE6.4 and pEE12.4 vectors (Lonza Biologics). A stable cell line secreting the HCMV trimer was generated by nucleofection of CHO-K1 SV line (GS-System, Lonza). For protein expression, Chinese hamster ovary (CHO) cells were seeded at 1 × 10 6 ml −1 in ProCho5 (Lonza). After 10 days, supernatants were collected and loaded on an immobilized-metal affinity chromatography (IMAC) column eluted with imidazole and further purified by affinity column StrepTactin II (Qiagen). Histidine and twin strep tags were removed by treatment with the TEV protease. Protease and uncleaved proteins were removed by negative chromatography. Finally, proteins were further purified by size-exclusion chromatography (Superdex 200 from GE Healthcare).
Soluble dimer was generated by transient transfection of gH2AgL in pEE6.4 vectors (Lonza Biologics). Dimer protein purification was performed as described above. Biolayer interferometry experiment. A FortéBio Octet Red384 instrument was used to measure the binding of gHgLgO trimer to immobilized PDGFRα-Fc receptor. PDGFRα-Fc receptor at 10 nM was loaded over a period of 8 min on Protein G tips and Biosensor tips were then equilibrated for 2 min before measuring association of the gHgLgO trimer for 8 min and dissociation for 10 min. Protein G sensors loaded with PDGFRα-Fc complexes were blocked and saturated for 20 min in a solution containing an unspecific human IgG1 at 60 nM before being dipped in a new well containing the gHgLgO trimer at 10 nM to form the complex. In a following step, the sensors were dipped into anti-gH neutralizing antibodies (13H11 and 11B12 at 14 nM) or anti-pUL128 antibody (15D8 at 14 nM) as control. Assays were performed with agitation set to 1,000 r.p.m. in PBS supplemented with 0.01% BSA and 0.002% Tween-20. Data analysis and curve fitting were carried out using Octet software, version 8.0.
Surface plasmon resonance. Experiments were carried out at 25°C on a ProteON XPR-36 instrument (Bio-Rad Laboratories) in a PBS buffer (Gibco, Invitrogen) and 0.05% Tween-20. The indicated proteins were immobilized on a GLM sensor chip surface through amine coupling at 1,000 response units (RU) and a blank surface with no protein was created under identical coupling conditions for use as a reference. Analyte proteins (gHgL dimer, gHgLgO trimer and gHgLpUL128L pentamer) were injected at a flow rate of 100 µl min -1 , at concentrations of 100, 75, 50, 25 and 12.5 nM in different sensor channels. Data were processed using Proteon software and double referenced by subtraction of the blank surface and buffer-only injection before local fitting of the data. Curves were locally fitted to perform K D calculations.
Virus neutralization assay and microscopy analysis. Confluent layers of ARPE-19, MRC-9 or HAP1 cells in 96-well flat-bottom plates were infected with a fixed amount of virus. The MOI (0.5) was chosen to give 500 to 1,000 infected cells per microscopic field. At 48 h post-infection, the cells were fixed with 5% acetic acid in methanol for 7 min on ice, washed four times with PBS, and then stained with 0.5 µg ml -1 of mouse anti-pp72 antibody for 2 h on ice. After four PBS washes, cells were incubated with 1 µg ml -1 of a goat anti-mouse IgG (H+L), AlexaFluor 594 conjugated (Invitrogen). After four PBS washes, cells were counterstained with 4′,6-diamidino-2-phenylindole (DAPI); images were acquired on a BD Pathway bioimaging system and the percentage of infected cells was automatically calculated by BD AttoVision software. The numbers of infected cells were plotted as histograms, and dose-response curves were generated by plotting the relative infected cells against the ligand or antibody dilutions.
Statistical analysis.
No statistical methods were used to predetermine the sample size. Data were analysed with Prism 6 (GraphPad Software) using the two-tailed non-parametric Mann-Whitney U test for comparison of two groups, or the Kruskall-Wallis test (and Dunn's posttest) when three or more groups were compared.
